CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 119 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,493,818 | +713.4% | 2,129,813 | +1084.6% | 0.02% | +666.7% |
| Q2 2023 | $5,715,683 | +50298.4% | 179,795 | -61.3% | 0.00% | -57.1% |
| Q1 2023 | $11,341 | -98.0% | 464,990 | +2225.0% | 0.01% | – |
| Q3 2022 | $565,000 | -91.0% | 20,000 | -91.6% | 0.00% | -100.0% |
| Q2 2022 | $6,301,000 | +296.8% | 238,300 | +425.2% | 0.00% | +200.0% |
| Q1 2022 | $1,588,000 | -19.2% | 45,371 | -25.1% | 0.00% | 0.0% |
| Q4 2021 | $1,965,000 | +442.8% | 60,602 | +393.9% | 0.00% | – |
| Q3 2021 | $362,000 | -93.8% | 12,270 | -97.1% | 0.00% | -100.0% |
| Q1 2021 | $5,849,000 | +791.6% | 426,016 | +976.6% | 0.00% | – |
| Q4 2020 | $656,000 | – | 39,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,713,470,000 | 41.39% |
| Perceptive Advisors | 6,511,727 | $184,021,000 | 5.34% |
| Finepoint Capital LP | 536,901 | $15,173,000 | 4.99% |
| Artal Group S.A. | 2,000,000 | $56,520,000 | 2.41% |
| Rock Springs Capital Management LP | 2,499,148 | $70,626,000 | 1.82% |
| Ikarian Capital, LLC | 178,100 | $5,033,000 | 1.00% |
| Hood River Capital Management LLC | 896,572 | $25,337,000 | 0.97% |
| Frazier Life Sciences Management, L.P. | 393,000 | $11,106,000 | 0.86% |
| HighVista Strategies LLC | 23,611 | $667,000 | 0.38% |
| FEDERATED HERMES, INC. | 3,313,333 | $93,635,000 | 0.27% |